DiMaio J M, Wait M A
Division of Thoracic and Cardiovascular Surgery, University of Texas, Southwestern Medical Center, Dallas, USA.
Chest Surg Clin N Am. 1999 Feb;9(1):97-111.
The advent of improved medical therapy with multidrug HIV medicines including protease inhibitors has prolonged life expectation of patients with HIV infection. The risk of perinatal transmission has also decreased with education and antiviral medications. Education of all groups about precautions to decrease HIV transmission appears to have resulted in a decline in the disease incidence; however, this trend has not been mirrored in other countries. All of these factors combine to increase the probability that the surgeon's role to take care of patients with HIV-related illnesses could be significant in the future. The thoracic surgeon may be called upon to assist in the diagnosis and treatment of HIV-infected patients with thoracic complications including pulmonary, cardiac, and esophageal problems. The morbidity and mortality of procedures performed on these patients appear to be no different than patients without HIV. We use very aggressive treatment strategies in patients with AIDS and HIV infections. The use of VATS, especially in the treatment of pneumothoraces and empyemas, should be used and has been shown to be safe and efficacious.
包括蛋白酶抑制剂在内的多种抗艾滋病毒药物带来的改良医学疗法,延长了艾滋病毒感染者的预期寿命。随着教育普及和抗病毒药物的使用,围产期传播风险也有所降低。向所有群体开展关于降低艾滋病毒传播预防措施的教育,似乎已使该疾病发病率有所下降;然而,这一趋势在其他国家并未得到体现。所有这些因素共同作用,增加了外科医生在未来照顾艾滋病毒相关疾病患者方面发挥重要作用的可能性。胸外科医生可能会被要求协助诊断和治疗患有肺部、心脏和食管等胸部并发症的艾滋病毒感染患者。对这些患者进行手术的发病率和死亡率似乎与未感染艾滋病毒的患者并无差异。我们对艾滋病和艾滋病毒感染患者采用非常积极的治疗策略。应使用电视辅助胸腔镜手术(VATS),尤其是在治疗气胸和脓胸方面,并且已证明其安全有效。